HCA Healthcare (HCA)
(Delayed Data from NYSE)
$371.89 USD
+0.31 (0.08%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $371.89 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth D Momentum A VGM
Brokerage Reports
HCA Healthcare, Inc. [HCA]
Reports for Purchase
Showing records 261 - 280 ( 288 total )
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Proposed FY15 IPPS Rates Slightly Worse than Expected
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Reform Impact Minimal w/1Q Slightly Below; Outlook Reaffirmed
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Healthcare Facilities: Recent Data Suggest Potential for Reform-Related Upside
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Growth in Surgeries & Acuity Offsets Volume Softness
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
4Q in Line with Pre-Announcement; 2014 Outlook Slightly Below Consensus
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Afternoon Call Summary
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Raising Estimates Slightly; Reform Upside More Likely in 2015 & 2016
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Pre-Announces Better than Expected 3Q on Higher Pricing/Acuity
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Increased Patient Acuity, Cost Management Drive Upside
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Pre-Announces Better than Expected 2Q but Details Are Light
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Initiating Coverage with a HOLD Rating
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Health Care Sector Research-Initiating Coverage
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
4Q Review: Monster EPS Beat; 2012 Guidance Solid; Reiterate Hold on Potential Headline Risk over the next 12 Months
Provider: AURIGA USA
Analyst: LOSEV G